Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by coyote13on Nov 13, 2017 5:44pm
241 Views
Post# 26955019

RE:RE:Insider Trading reports through TD & INK Insider Trading

RE:RE:Insider Trading reports through TD & INK Insider Trading33:

From Sedi I found the following info:

Insider filings were dated  Nov 11/17

Rights exercised, shares acquired and shares sold  were transacted  on Nov 6/17

Exercise prices ranged from $1.23 to $2.87

Common shares would appear to have been sold en bloc at $1.5089

There were 11 senior officers who have filed on SEDI. I have summarized the common share activity for the top 5:


Officer    Acq via Rights Exercise         Avg Cost              Sold                Inc in Holding .  
Laurin              1,131,795 .                     1.86 .            1,131,795                 -
Pritchard .          423,305                        1.89                 207,818                215,387
Sartore .             343,657 .                      1.88                 343,657                  -
Moran                185,863                         1.73                    -                        185,863
Gagnon             181,387                         1.78                 144,656                  36,731


Some tax planning perhaps behind the decision to exercise and sell?

I am not fussed about this activity. These execs have alot of $$$ tied up in PLI. Timing not the best since shorters could work this into their "plan" I suppose.

But someone bought 1.9 million shares and paid 1.5089 per share last week. Hmm. Did we trade their last week?

Coyote13
Bullboard Posts